Levosimendan in the modern treatment of patients with acute heart failure of various aetiologies.
acute decompensated heart failure
inotropic drugs
levosimendan
Journal
Archives of medical science : AMS
ISSN: 1734-1922
Titre abrégé: Arch Med Sci
Pays: Poland
ID NLM: 101258257
Informations de publication
Date de publication:
2021
2021
Historique:
received:
04
10
2017
accepted:
29
11
2017
entrez:
22
3
2021
pubmed:
7
11
2019
medline:
7
11
2019
Statut:
epublish
Résumé
Acute decompensated heart failure (ADHF) is a common clinical problem associated with a high mortality rate. Because ADHF has various aetiologies, there are a range of therapeutic options, among others, positive inotropes (inotropic drugs). As an inotropic agent whose mechanism is different than that of "classical" medicines, levosimendan (LSM) is one of the most common therapeutic options. Despite many publications on LSM, some issues related to its application remain unclear. The authors of this paper have attempted to summarise expert recommendations and reports available in the literature.
Identifiants
pubmed: 33747264
doi: 10.5114/aoms.2018.77055
pii: 80898
pmc: PMC7959091
doi:
Types de publication
Journal Article
Langues
eng
Pagination
296-303Informations de copyright
Copyright: © 2019 Termedia & Banach.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Intensive Care Med. 2013 Aug;39(8):1497-8
pubmed: 23673402
J Trauma. 2010 May;68(5):E108-10
pubmed: 20453750
Crit Care Med. 2013 Oct;41(10):2328-35
pubmed: 23921271
Eur J Heart Fail. 2010 Apr;12(4):404-10
pubmed: 20335355
Lancet. 2002 Jul 20;360(9328):196-202
pubmed: 12133653
Eur J Heart Fail. 2014 Mar;16(3):281-8
pubmed: 24464960
Crit Care Med. 2001 Nov;29(11):2185-93
pubmed: 11700420
Liver Transpl. 2014 Mar;20(3):361-75
pubmed: 24273004
J Cardiothorac Surg. 2014 Nov 18;9:167
pubmed: 25399779
Middle East J Anaesthesiol. 2010 Oct;20(6):869-72
pubmed: 21526676
Intensive Care Med. 2005 May;31(5):638-44
pubmed: 15812624
Cardiovasc Drugs Ther. 2013 Dec;27(6):581-90
pubmed: 23929366
Anaesthesiol Intensive Ther. 2015;47(2):175-80
pubmed: 25940334
Clin Res Cardiol. 2014 Jul;103(7):505-13
pubmed: 24368740
Int J Cardiol. 2010 Feb 4;138(3):281-9
pubmed: 18817994
Int J Cardiol. 2014 Jun 15;174(2):360-7
pubmed: 24780540
Minerva Anestesiol. 2010 Apr;76(4):276-86
pubmed: 20332741
Cardiovasc Ther. 2013 Dec;31(6):e133-7
pubmed: 24119220
Int J Cardiol. 2012 Aug 23;159(2):82-7
pubmed: 21784540
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Anesth Analg. 2009 Mar;108(3):790-2
pubmed: 19224785
J Card Fail. 2007 Aug;13(6):417-21
pubmed: 17675054
Eur J Heart Fail. 2002 Aug;4(4):515-29
pubmed: 12167393
J Am Coll Cardiol. 2000 Nov 15;36(6):1903-12
pubmed: 11092663
J Crit Care. 2012 Jun;27(3):318.e1-6
pubmed: 21855289
J Cardiothorac Vasc Anesth. 2013 Apr;27(2):361-6
pubmed: 22658687
Crit Care Med. 2010 Oct;38(10):2016-23
pubmed: 20657271
J Med Toxicol. 2009 Mar;5(1):3-7
pubmed: 19191208
Crit Care Med. 2009 Dec;37(12):3017-23
pubmed: 19661807
Anesth Analg. 2004 Mar;98(3):822-4, table of contents
pubmed: 14980944
Int J Cardiol. 2014 Oct 20;176(3):1435-7
pubmed: 25147072
J Clin Pharmacol. 2002 Jan;42(1):43-51
pubmed: 11808823
Wien Klin Wochenschr. 2014 Aug;126(15-16):495-9
pubmed: 24652017
Case Rep Med. 2010;2010:
pubmed: 20814559
N Engl J Med. 2016 Oct 5;375(17):1638-1648
pubmed: 27705084
Eur Heart J. 2013 Mar;34(10):742-9
pubmed: 23091203
J Cardiovasc Pharmacol. 2014 Feb;63(2):107-12
pubmed: 24126568
Am J Cardiol. 2005 Sep 19;96(6A):47G-58G
pubmed: 16181823
Eur J Heart Fail. 2007 Jan;9(1):75-82
pubmed: 16829185
Crit Care Med. 2007 Mar;35(3):952-3
pubmed: 17421086
Int J Cardiol. 2005 Sep 1;103(3):248-55
pubmed: 16098385
J Emerg Trauma Shock. 2010 Jan;3(1):94
pubmed: 20165732
Crit Care Med. 2012 Feb;40(2):634-46
pubmed: 21963578
Crit Care Med. 2012 Jan;40(1):223-32
pubmed: 21926590
J Zhejiang Univ Sci B. 2013 May;14(5):400-15
pubmed: 23645177
Int J Cardiol. 2008 Jan 24;123(3):346-7
pubmed: 17324479
Am J Emerg Med. 2016 Feb;34(2):298-306
pubmed: 26669277